BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paudel S, Mehtani D, Puri N. Mast Cells May Differentially Regulate Growth of Lymphoid Neoplasms by Opposite Modulation of Histamine Receptors. Front Oncol 2019;9:1280. [PMID: 31824856 DOI: 10.3389/fonc.2019.01280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Yao F, Zhan Y, Pu Z, Lu Y, Chen J, Deng J, Wu Z, Chen B, Chen J, Tian K, Ni Y, Mou L. LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4+ T Cell in Gastric Cancer. Front Cell Dev Biol 2021;9:797339. [PMID: 34966745 DOI: 10.3389/fcell.2021.797339] [Reference Citation Analysis]
2 Sarasola MP, Táquez Delgado MA, Nicoud MB, Medina VA. Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect 2021;9:e00778. [PMID: 34609067 DOI: 10.1002/prp2.778] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Clauzure M, Táquez Delgado MA, Phillip JM, Revuelta MV, Cerchietti L, Medina VA. Histamine H4 Receptor Agonism Induces Antitumor Effects in Human T-Cell Lymphoma. Int J Mol Sci 2022;23:1378. [PMID: 35163302 DOI: 10.3390/ijms23031378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mehtani D, Puri N. Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies. Front Oncol 2021;11:731323. [PMID: 34631562 DOI: 10.3389/fonc.2021.731323] [Reference Citation Analysis]